Increased Transparency in Drug Pricing and Hospital Rules for 340B Program.
This act aims to increase transparency in the 340B drug discount program, which helps hospitals purchase medications at lower costs. It introduces new rules on which hospitals can participate and how they must report their drug expenditures and revenues. This should help citizens better understand how drug discounts work and whether hospitals pass savings on to patients.
Key points
A 2-year pause on new hospital registrations in the 340B program to establish clear participation rules.
Hospitals will need to disclose how much they earn from discounted drugs and how much they spend on charity care.
Introduction of special codes on drug claims to track which drugs were purchased with 340B discounts.
Greater oversight on which medical facilities (e.g., clinics) can benefit from discounts as part of a hospital.
Expired
Citizen Poll